Investors bank on medical robotics company co-founder

Executive Broadcasts

Latest Broadcasts

Stockgroup Information Systems Inc.

SWEB

Internet/Technology

URANIUM NORTH RESOURCES CORP

V.UNR

BASIC MATERIALS - METALS & MINING

Petro Vista Energy Corp

V.PTV

BASIC MATERIALS - ENERGY

Skyline Investor Relations

SKYLINE

Investor Relations

Constitution Mining Corp

CMIN

Basic Materials – Metals & Mining

TapImmune Inc.

TPIM

Healthcare

Visit the Executive Broadcast Center

INVESTOR MARKETPLACE

An excellent place to start your search for new investments!

add to favorites

print email

Investors bank on medical robotics company co-founder

5/15/2008 4:01:49 PM | From the news desk of 24/7 Wall St.

306 Reads | 1 Comments

Rate this

clarity
3

clarity : 3
Rate this:

overall quality
2 overall quality : 2
Average quality rating by the Stockhouse community.

credibility
3

credibility : 3
Rate this:

usefulness
3

usefulness : 3
Rate this:

Medical robotics manufacturer has a good pedigree.

Hansen Medical, Inc. (NASDAQ: HNSN, Bullboard) develops, manufactures, and sells medical robotics for positioning, manipulation, and control of catheters and catheter-based technologies, mainly for the heart.

Its first FDA clearance came in May, 2007, and it has a CE Mark from the EU after it became public in late 2006. This stock ran considerably after its IPO through the May approval at the FDA, but it peaked in late 2007 and sold off to the point that shares now sit at half the price.

The sales issues are the factor. It generated only $10 million in total revenues for 2007. Analysts are also expecting about $37 million in 2008 revenues and more than $73.6 million in revenues for 2009. After its 50% stock haircut, this one has a market cap of $421 million.

On of the reasons that investors are so interested in Hansen is that Robert Younge, its chief technical officer and co-founder, is also one of the founders of Intuitive Surgical (NASDAQ: ISRG, Bullboard), a company with great similarities: Robotics and robotics, public stock and public stock. Investors saw a run of 20-fold over the last five years in Intuitive Surgical stock, so the hope is that they get a repeat.

The issues at hand are the company's revenue growth, loss expectations and cash needs. It is expected to lose money in 2008 and in 2009 and it only had about $48.5 million in cash on last look. Any hiccups that cause added pain may shake analysts and investors alike as the average analyst target sits north of $30.00.

ABOUT THE AUTHOR

From the news desk of 24/7 Wall St.

This report was prepared by 24/7 Wall St., LLC exclusively for Stockhouse.

Stockhouse Conflict and Disclosure Policy:

Stockgroup Media Inc., owners and operators of Stockhouse.ca/com, has established rules to ensure that there is no appearance of impropriety on the part of any Stockhouse writers who discuss or name individual public companies in the content published on the Stockhouse websites. The content of Stockhouse Editorial articles are the opinion of the writer and any reliance on the content of these articles shall be at your sole risk.

Stockhouse Editorial writers may own, buy, or sell shares in public companies mentioned in their articles. Please be advised that a conflict may exist and that any investment decisions you make are your own responsibility. Additionally, our Editorial writers are not registered investment advisors. You should not make any kind of investment decision in relation to these articles or stocks discussed in them without first obtaining independent investment advice from a registered investment advisor.

Facts relied upon by our Editorial writers in arriving at their opinions are generally provided by the subject companies or gathered by our Editorial writers from other public and/or private sources. These facts may be in error and if so, the opinions of our Editorial writers may be materially different.

Rules applying to Stockhouse Editorial Writers

Stockhouse Editorial writers may own stock of any company they cover, but at the bottom of the article or within the article they must clearly and prominently state their ownership position in the company.

Stockhouse Editorial writers cannot solicit, accept, or agree to receive anything of value given or paid with the intent of influencing their editorial articles published on Stockhouse.

Stockhouse Editorial writers are not permitted to write articles that attempt to influence or benefit persons connected to the writer such as family or friends, , except where disclosure is made in the same way as if the writer him/herself owns stock.

Stockhouse notifies each Editorial writer about these rules but in case of a possible breach of our rules, we may not be in a position to find out or investigate the facts. We rely on the integrity of our writers to ensure that our rules are followed.

FREE REPORTS